These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2635219)

  • 1. Uptake of 3H-spiperone by lymphocytes in schizophrenia.
    Itzchaky S; Lerer B; Ebstein RP
    J Psychiatr Res; 1989; 23(3-4):221-7. PubMed ID: 2635219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequestration of [3H]spiperone by lymphocytes in schizophrenics and their first-degree relatives: a limited vulnerability marker?
    Griffiths RS; Chung-a-on KO; Griffiths KD; Payne JW; Davies JI
    J Psychiatr Res; 1992 Jan; 26(1):77-84. PubMed ID: 1560411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients.
    Grodzicki J; Pardo M; Schved G; Schlosberg A; Fuchs S; Kanety H
    Biol Psychiatry; 1990 Jun; 27(12):1327-30. PubMed ID: 1973057
    [No Abstract]   [Full Text] [Related]  

  • 4. 3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects.
    Wodarz N; Fritze J; Riederer P; Beckmann H
    Biol Psychiatry; 1993 May; 33(10):727-33. PubMed ID: 8353168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia.
    Bondy B; Ackenheil M
    J Psychiatr Res; 1987; 21(4):521-9. PubMed ID: 3481637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between uptake to lymphocytes from schizophrenic patients and therapeutic efficacy].
    Shimogawa S; Kaku H; Yoshimoto S; Nakane Y
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):239-46. PubMed ID: 2877529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-spiperone binding in platelet membranes: a possible biological marker for schizophrenia.
    Sethi BB; Kumar P; Agarwal AK; Seth PK; Trivedi JK
    Acta Psychiatr Scand; 1986 Feb; 73(2):186-90. PubMed ID: 3705995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine uptake by platelets from subjects with schizophrenia: a correlation with the delusional state of the patient.
    Dean B; Kulkarni J; Copolov DL; Shrikanthan P; Malone V; Hill C
    Psychiatry Res; 1992 Jan; 41(1):17-24. PubMed ID: 1561286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodology of 3H-spiperone binding to lymphocytes.
    Bondy B; Ackenheil M; Engel RR
    J Psychiatr Res; 1990; 24(1):83-92. PubMed ID: 1694898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3H-spiperone binding to lymphocytes in neuroleptic-naive-schizophrenia and the effect of neuroleptic treatment.
    Laufer N; Spivak B; Holdengreber V; Zipser J; Kosower N; Ragolsky M; Weizman A
    Clin Neuropharmacol; 1999; 22(2):110-4. PubMed ID: 10202608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The binding of 3H-spiperone to lymphocytes in patients with schizophrenia and first-degree relatives: in search of a genetic marker].
    Heinze G; King GB; Huerto L; Ortega H; Cortés J; Ariza JR
    Gac Med Mex; 1994; 130(4):241-5. PubMed ID: 8964331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte 3H-spiroperidol binding in schizophrenia: preliminary findings.
    Rotstein E; Mishra RK; Singal DP; Barone D
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):729-32. PubMed ID: 6686701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of 3H-spiperone to human peripheral lymphocytes: absence of stereospecific high-affinity binding.
    Feenstra A; Coggiano MA; Wyatt RJ
    Psychiatry Res; 1989 Dec; 30(3):259-64. PubMed ID: 2482515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiperone binding capacity in lymphocytes of patients with alcohol- and drug-induced psychosis: preliminary results.
    Soyka M; Bondy B; Peuker B; Ackenheil M
    J Stud Alcohol; 1994 Jul; 55(4):503-7. PubMed ID: 7934059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
    Coppens HJ; Slooff CJ; Paans AM; Wiegman T; Vaalburg W; Korf J
    Biol Psychiatry; 1991 Apr; 29(7):629-34. PubMed ID: 1675892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia?
    Bondy B; Ackenheil M; Elbers R; Fröhler M
    Psychiatry Res; 1985 May; 15(1):41-8. PubMed ID: 2409568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-spiroperidol binding to human peripheral mononuclear cells: methodological aspects.
    Wodarz N; Fritze J; Kornhuber J; Riederer P
    Biol Psychiatry; 1992 Feb; 31(3):291-303. PubMed ID: 1532133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glucocorticoid dependent increase of spiperone binding sites on lymphocytes from schizophrenics in vitro.
    Halbach M; Henning U
    Pharmacopsychiatry; 1989 Sep; 22(5):169-73. PubMed ID: 2813506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.